Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Thymogen vs VIP (Vasoactive Intestinal Peptide)
An educational, source-based comparison of Thymogen and VIP (Vasoactive Intestinal Peptide) — how each peptide works, what it's researched for, and what to know before going deeper.
A synthetic dipeptide (Glu-Trp) in the Khavinson bioregulator family. Research suggests modulation of thymic and immune cell gene expression, supporting T-cell maturation and innate immune response in aged models.
- Immunosenescence and age-related immune decline
- Post-infectious immune recovery
- Chronic fatigue and immune dysregulation
- • Russian bioregulator research; limited independent replication.
- • Not FDA-approved.
Neuropeptide researched for immune modulation and lung protection.
A 28-amino-acid neuropeptide with broad immunomodulatory, anti-inflammatory, and bronchodilatory effects. Acts via VPAC1 and VPAC2 receptors to regulate T-cell function, macrophage polarization, and airway smooth muscle tone.
- Acute respiratory distress syndrome (ARDS)
- Chronic inflammatory conditions
- Autoimmune modulation
- Bronchial asthma and COPD
- • Short half-life limits therapeutic utility; analogs in development.
- • Not FDA-approved in native form.
Thymogen vs VIP (Vasoactive Intestinal Peptide) — Key differences
- Class: Thymogen is classified as Immune · Bioregulator, while VIP (Vasoactive Intestinal Peptide) is Immune · Respiratory.
- Primary research focus: Thymogen — immunosenescence and age-related immune decline; VIP (Vasoactive Intestinal Peptide) — acute respiratory distress syndrome (ards).
- Tag: Immune · Bioregulator vs Immune · Respiratory.